Literature DB >> 22819858

Next generation phage display by use of pVII and pIX as display scaffolds.

Geir Åge Løset1, Inger Sandlie.   

Abstract

Phage display technology has evolved to become an extremely versatile and powerful platform for protein engineering. The robustness of the phage particle, its ease of handling and its ability to tolerate a range of different capsid fusions are key features that explain the dominance of phage display in combinatorial engineering. Implementation of new technology is likely to ensure the continuation of its success, but has also revealed important short comings inherent to current phage display systems. This is in particular related to the biology of the two most popular display capsids, namely pIII and pVIII. Recent findings using two alternative capsids, pVII and pIX, located to the phage tip opposite that of pIII, suggest how they may be exploited to alleviate or circumvent many of these short comings. This review addresses important aspects of the current phage display standard and then discusses the use of pVII and pIX. These may both complement current systems and be used as alternative scaffolds for display and selection to further improve phage display as the ultimate combinatorial engineering platform.
Copyright © 2012 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 22819858     DOI: 10.1016/j.ymeth.2012.07.005

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  11 in total

Review 1.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

Review 2.  Peptide aptamers: development and applications.

Authors:  Sergey Reverdatto; David S Burz; Alexander Shekhtman
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

3.  Construction of helper plasmid-mediated dual-display phage for autoantibody screening in serum.

Authors:  Kaushik Rajaram; Veronique Vermeeren; Klaartje Somers; Veerle Somers; Luc Michiels
Journal:  Appl Microbiol Biotechnol       Date:  2014-04-25       Impact factor: 4.813

Review 4.  Phage Display Engineered T Cell Receptors as Tools for the Study of Tumor Peptide-MHC Interactions.

Authors:  Geir Åge Løset; Gøril Berntzen; Terje Frigstad; Sylvie Pollmann; Kristin S Gunnarsen; Inger Sandlie
Journal:  Front Oncol       Date:  2015-01-12       Impact factor: 6.244

Review 5.  Virus outbreaks in chemical and biological sensors.

Authors:  Inseong Hwang
Journal:  Sensors (Basel)       Date:  2014-07-25       Impact factor: 3.576

Review 6.  Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccines.

Authors:  Kyriakos A Hassapis; Dora C Stylianou; Leondios G Kostrikis
Journal:  Viruses       Date:  2014-12-17       Impact factor: 5.048

Review 7.  Chemical modulation of M13 bacteriophage and its functional opportunities for nanomedicine.

Authors:  Woo-Jae Chung; Doe-Young Lee; So Young Yoo
Journal:  Int J Nanomedicine       Date:  2014-12-12

8.  Multivalent pIX phage display selects for distinct and improved antibody properties.

Authors:  Lene S Høydahl; Nicolay R Nilssen; Kristin S Gunnarsen; M Fleur du Pré; Rasmus Iversen; Norbert Roos; Xi Chen; Terje E Michaelsen; Ludvig M Sollid; Inger Sandlie; Geir Å Løset
Journal:  Sci Rep       Date:  2016-12-14       Impact factor: 4.379

9.  Design and Characterization of a New pVII Combinatorial Phage Display Peptide Library for Protease Substrate Mining Using Factor VII Activating Protease (FSAP) as Model.

Authors:  Emrah Kara; Nis Valentin Nielsen; Bergrun Eggertsdottir; Bernd Thiede; Sandip M Kanse; Geir Åge Løset
Journal:  Chembiochem       Date:  2020-04-14       Impact factor: 3.164

10.  The development of inovirus-associated vector vaccines using phage-display technologies.

Authors:  Zachariah Stern; Dora C Stylianou; Leondios G Kostrikis
Journal:  Expert Rev Vaccines       Date:  2019-09-08       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.